Table 7.
Ranking score | HIVPR | FXa | DHFR | FGFr1 | P38 MAP | ADA | ER | AmpC |
---|---|---|---|---|---|---|---|---|
RMSD | 38 | 25 | 44 | 14 | 17 | 39 | 38 | 10 |
SP LGFE | 19 | 11 | 20 | 16 | 48 | 4 | 85 | 0 |
MC LGFE | 11 | 22 | 20 | 13 | 33 | 4 | 77 | 0 |
RMSD + SP LGFE | 42 | 33 | 53 | 29 | 60 | 43 | 85 | 10 |
RMSD + MC LGFE | 40 | 42 | 50 | 27 | 47 | 39 | 79 | 10 |
Percentage of active ligands=Nligands_in_10%/Nligands*100%, where Nligands_in_10% is the number of active ligands identified among the top 10% ranked compounds and Nligands is the total number of active ligands in the database for the target.